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Summary
On 5 May 2014, the Director-General o f the World Health Organization (WHO) accepted the 
recommendations o f an Emergency Committee, declaring the international spread o f polio to be a public 
health emergency o f international concern (PHEIC) under the authority o f the International Health 
Regulations (IHR) (2005) and issued vaccination requirements for travelers in order to prevent further 
spread o f the disease. IHR is an international agreement among countries to prevent, protect or control 
the international spread o f disease. A ll countries have agreed to be bound by recommended activities 
under IHR.
The “temporary recommendations” in response to this PHEIC, the second ever to be issued under IHR, 
will be reviewed and possibly revised by WHO’s Emergency Committee in three months. The burden for 
enforcement o f the polio vaccination requirements under this PHEIC declaration lies with polio-affected 
countries (termed “polio-infected” by WHO). A t this time, the United States government is not expected to 
implement requirements for entry into the United States.
U.S. clinicians should be aware o f possible new vaccination requirements for patients planning travel for 
greater than four weeks to countries with ongoing poliovirus transmission. The May 5 WHO statement 
names 10 such countries, three designated as “exporting wild poliovirus” (Cameroon, Pakistan and Syria 
[Syrian Arab Republic]) that should “ensure” recent (4 to 52 weeks before travel) polio boosters among all 
departing residents and long-term travelers (o f more than 4 weeks), and an additional seven countries 
“infected with wild poliovirus” (Afghanistan, Equatorial Guinea, Ethiopia, Iraq, Israel, Somalia and Nigeria) 
that should “encourage” recent polio vaccination boosters among residents and long-term travelers.
A t this time, CDC is not aware o f what specific steps will be taken by these 10 countries to comply with 
the PHEIC declaration. U.S. citizens who plan to travel to any o f the polio infected countries should have 
documentation o f a polio booster in their yellow International Certificate o f Vaccination in order to avoid 
delays in transit.
Background
Currently 10 countries have active transmission of wild poliovirus (WPV) that could spread to other 
countries through international travel. From January through April 2014, months normally considered the 
low-transmission season for polio, the virus already has been carried to three countries: from Pakistan to 
Afghanistan, from Syria to Iraq, and from Cameroon to Equatorial Guinea. WHO considers this an 
“extraordinary event” and a public health risk to other countries. If the current spread of WPV continues, 
cases could multiply considerably as the high-transmission season has already begun. The 
consequences of further international spread are particularly acute today given that several countries with 
complex humanitarian emergencies or other major challenges are bordering the infected countries.
Recommendations
Because of the substantial progress of the polio eradication initiative in 2012-2013, and in order to 
harmonize CDC recommendations with WHO recommendations, CDC now recommends an adult 
inactivated poliovirus (IPV) booster dose for travelers to countries with active WPV circulation. Countries 
are considered to have active WPV circulation if they have ongoing endemic circulation, active polio 
outbreaks, or environmental evidence of active WPV circulation. Travelers working in health care settings, 
refugee camps, or other humanitarian aid settings in these countries may be at particular risk.
Domestic clinicians should provide the following information to their patients planning international travel 
to countries experiencing polio outbreaks/active transmission:
1. Travelers to polio-affected areas should receive polio vaccination or a booster polio vaccination 
prior to travel following the guidance at http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3- 
infectious-diseases-related-to-travel/poliomyelitis.
2. Travelers also may be impacted by new WHO Polio Vaccination Recommendations in countries 
with ongoing poliovirus transmission:
• For travel to Pakistan, Cameroon, and Syria (countries exporting WPV)
o These governments have been asked to ensure that all residents and long­
term visitors (of more than 4 weeks) receive an additional dose of oral polio 
vaccine (OPV) or inactivated poliovirus vaccine (IPV) between 4 weeks and 
12 months prior to any international travel and have the dose documented. 
o Residents and long-term visitors who are currently in those countries who 
must travel with fewer than 4 weeks’ notice and have not been vaccinated 
with OPV or IPV within the previous 4 weeks to 12 months receive a dose at 
least by the time of departure. 
o These measures should be maintained until at least 6 months have passed 
without new exportations with documentation that there is strong surveillance 
for the virus and that people are being vaccinated in all infected and high-risk 
areas; without such documentation, these measures should be maintained 
until at least 12 months have passed without new exportations. 
o At this time, CDC has not seen documentation from any of these three 
countries specifying how these new requirements will be implemented.
• For travel to Afghanistan, Equatorial Guinea, Ethiopia, Iraq, Israel, Somalia, and 
Nigeria (In countries that currently have ongoing poliovirus transmission but have not 
exported WPV to another country in the past 6 months)
o These governments are encouraged to ensure that residents and long-term 
visitors receive an additional dose of OPV or IPV 4 weeks to 12 months prior 
to each international journey; current residents of those countries 
undertaking travel with fewer than 4 weeks’ notice who have not been 
vaccinated with a dose of OPV or IPV within the previous 4 weeks to 12 
months should be encouraged to receive a dose by the time of departure and 
have the dose documented. 
o These measures should be maintained until at least 6 months have passed 
without the detection of WPV transmission in the country from any source. 
o At this time, CDC has not seen documentation from any of these seven 
countries specifying how these new requirements will be implemented. 
o Travelers should also be aware that in the event of new international spread 
from any one of these seven infected countries, that country would be asked 
to immediately implement the vaccination requirements for ‘States currently 
exporting wild poliovirus.’
Travelers to or from all 10 countries should be given a WHO/IHR International Certificate of Vaccination 
or Prophylaxis (http://www.who.int/ihr/ports airports/icvp/en/) to record and serve as proof of their polio 
vaccination.
Guidance
CDC routinely recommends that anyone planning travel to a polio-affected country be fully vaccinated 
against polio and that, in addition, adults should receive a one-time booster dose of polio vaccine. 
Because of the recent PHEIC declaration, anyone staying in any of the polio-affected countries for more 
than four (4) weeks may be required to have a polio booster shot within the 4 weeks to twelve months 
prior to departure from that country. This booster should be documented in the yellow International 
Certificate of Vaccination in order to avoid delays in transit or forced vaccination in country. Either oral 
poliovirus vaccine (OPV) or inactivated poliovirus vaccine (IPV) may be used for this booster, however 
only IPV is currently available in the United States.
For more information:
• http://www.polioeradication.Org/Portals/0/Document/Emerqency/PolioPHEICquidance.pdf
• Contact Steven Wassilak, MD, at axj3@cdc.gov or 404-488-7100 (available 24 hours).
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